Manufacturing Investments: Cell and Gene Therapies
The Center for Breakthrough Medicines, a new CDMO and specialty investment company with a planned investment of $1.1-billion for a cell- and gene-therapy manufacturing facility in King of Prussia, Pennsylvania. The CDMO is occupying over 40% of The Discovery Labs’s 1.6-million-square-foot biotech, healthcare and life-sciences campus in King of Prussia. The new CDMO will provide preclinical through commercial manufacturing of cell and gene therapies and component raw materials as well as process development, plasmid DNA, viral vectors, cell banking, cell processing, and support testing capabilities. Renovations are underway to construct a total of 86 plasmid, viral vector production, universal cell processing, cGMP testing, process development and cell-banking suites. As of the company’s announcement in January 2020, the company was in the process of reserving capacity for late 2020…